Dr. Michael V. Orlov, MD

Dr. Orlov practices at Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System.

Dr. Orlov's NPI, 1407844020, was assigned on October 7, 2005. Dr. Orlov holds Massachusetts license 157168.

Dr. Orlov's primary practice is Boston Medical Center - Brighton, at 736 Cambridge Street, Nevins Building, Brighton, MA 02135 in Suffolk County. The practice phone is (617) 789-3000.

Dr. Orlov's primary practice is Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System. Dr. Orlov is also affiliated with Newton-Wellesley Hospital. The medical group on file is Steward Medical Group. Dmand AI also links Dr. Orlov to 3 more hospitals, 5 medical groups, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orlov practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Orlov's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Orlov's licenses on file in 2 states: Massachusetts and New Hampshire.

CMS data shows 1,811 Medicare services from Dr. Orlov across 18 procedure codes in 2024, for 414 Medicare patients. Medicare paid $81,929 for them.

CMS counts 414 Medicare patients who saw Dr. Orlov in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orlov's median patient age at 76, with 41% women.

In 2024, Dr. Orlov wrote 5,414 Medicare Part D claims for 197 patients. 87% of them were for generic drugs. CMS names the drug for 5,094 of them, across 103 drugs with 11 or more claims each, at $432,449 in total drug cost. In 2023, CMS named 4,959 claims across 94 drugs.

Dr. Orlov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orlov as offering telehealth. CMS counts 46 procedures of pacemaker insertion or repair by Dr. Orlov, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Orlov, published from 2010 to 2025. 2012 was the busiest year, with 3. The most frequent topics are Heart Failure, Atrial Fibrillation and Cardiac Pacing, Artificial. Dr. Orlov has published most often in Heart Rhythm. Dr. Orlov's most frequent co-authors are David G. Benditt, MD, Spyridon T. Akrivakis, MD and Zoubin Alikhani, MD.

Dmand AI links Dr. Orlov to 2 clinical trials. Conditions studied include Heart Failure, Ventricular Dysfunction, Left and Heart Diseases. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 253 general payments to Dr. Orlov from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Abbott Laboratories paid the most, $25,032.